KEQU Fundamental Analysis - KEWAUNEE SCIENTIFIC CP

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to KEQU. KEQU was compared to 187 industry peers in the Health Care Equipment & Supplies industry. KEQU has only an average score on both its financial health and profitability. KEQU is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year KEQU was profitable.

KEQU had a positive operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: KEQU reported negative net income in multiple years.

In multiple years KEQU reported negative operating cash flow during the last 5 years.

1.2 Ratios

With an excellent Return On Assets value of 5.86%, KEQU belongs to the best of the industry, outperforming 83.96% of the companies in the same industry.

The Return On Equity of KEQU (17.69%) is better than 92.51% of its industry peers.

The Return On Invested Capital of KEQU (9.80%) is better than 90.37% of its industry peers.

Measured over the past 3 years, the Average Return On Invested Capital for KEQU is in line with the industry average of 8.08%.

		Industry Rank	Sector Rank
ROA	5.86%
ROE	17.69%
ROIC	9.8%

ROA(3y)6.79%

ROA(5y)2.22%

ROE(3y)17.94%

ROE(5y)5.55%

ROIC(3y)9.9%

ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 4.74%, KEQU is in the better half of the industry, outperforming 75.94% of the companies in the same industry.

Looking at the Operating Margin, with a value of 7.39%, KEQU is in the better half of the industry, outperforming 75.40% of the companies in the same industry.

Looking at the Gross Margin, with a value of 28.63%, KEQU is doing worse than 77.01% of the companies in the same industry.

In the last couple of years the Gross Margin of KEQU has grown nicely.

		Industry Rank	Sector Rank
OM	7.39%
PM (TTM)	4.74%
GM	28.63%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y25.96%

GM growth 5Y12.54%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so KEQU is still creating some value.

Compared to 1 year ago, KEQU has about the same amount of shares outstanding.

Compared to 5 years ago, KEQU has more shares outstanding

The debt/assets ratio for KEQU is higher compared to a year ago.

2.2 Solvency

KEQU has an Altman-Z score of 3.13. This indicates that KEQU is financially healthy and has little risk of bankruptcy at the moment.

The Altman-Z score of KEQU (3.13) is better than 70.05% of its industry peers.

The Debt to FCF ratio of KEQU is 5.19, which is a neutral value as it means it would take KEQU, 5.19 years of fcf income to pay off all of its debts.

KEQU has a better Debt to FCF ratio (5.19) than 80.21% of its industry peers.

KEQU has a Debt/Equity ratio of 0.96. This is a neutral value indicating KEQU is somewhat dependend on debt financing.

KEQU has a worse Debt to Equity ratio (0.96) than 77.54% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.96
Debt/FCF	5.19
Altman-Z	3.13

ROIC/WACC1.2

WACC8.18%

2.3 Liquidity

KEQU has a Current Ratio of 2.20. This indicates that KEQU is financially healthy and has no problem in meeting its short term obligations.

The Current ratio of KEQU (2.20) is comparable to the rest of the industry.

A Quick Ratio of 1.59 indicates that KEQU should not have too much problems paying its short term obligations.

KEQU has a Quick ratio (1.59) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	2.2
Quick Ratio	1.59

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for KEQU have decreased strongly by -39.71% in the last year.

KEQU shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -18.78% yearly.

The Revenue has grown by 18.02% in the past year. This is quite good.

Measured over the past years, KEQU shows a small growth in Revenue. The Revenue has been growing by 5.68% on average per year.

EPS 1Y (TTM)-39.71%

EPS 3Y-27.83%

EPS 5Y-18.78%

EPS Q2Q%25.81%

Revenue 1Y (TTM)18.02%

Revenue growth 3Y4.46%

Revenue growth 5Y5.68%

Sales Q2Q%36.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 66.87, which means the current valuation is very expensive for KEQU.

KEQU's Price/Earnings ratio is a bit cheaper when compared to the industry. KEQU is cheaper than 65.78% of the companies in the same industry.

Compared to an average S&P500 Price/Earnings ratio of 26.82, KEQU is valued quite expensively.

		Industry Rank	Sector Rank
PE	66.87
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KEQU indicates a rather cheap valuation: KEQU is cheaper than 91.98% of the companies listed in the same industry.

Based on the Price/Free Cash Flow ratio, KEQU is valued cheaply inside the industry as 94.65% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	13.29
EV/EBITDA	9.66

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

KEQU does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

KEWAUNEE SCIENTIFIC CP

NASDAQ:KEQU (8/19/2025, 2:27:47 PM)

After market: 56.5 -0.34 (-0.6%)

56.84

-0.06 (-0.11%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)06-25 2025-06-25/amc

Earnings (Next)09-10 2025-09-10

Inst Owners40.64%

Inst Owner Change-4.04%

Ins Owners16.04%

Ins Owner Change2.02%

Market Cap167.68M

Analysts82.86

Price TargetN/A

Short Float %1.81%

Short Ratio3.11

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	66.87
Fwd PE	N/A
P/S	0.7
P/FCF	13.29
P/OCF	11.34
P/B	2.6
P/tB	4.91
EV/EBITDA	9.66

EPS(TTM)0.85

EY1.5%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)4.28

FCFY7.52%

OCF(TTM)5.01

OCFY8.82%

SpS81.52

BVpS21.85

TBVpS11.57

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	5.86%
ROE	17.69%
ROCE	12.6%
ROIC	9.8%
ROICexc	10.96%
ROICexgc	14.39%
OM	7.39%
PM (TTM)	4.74%
GM	28.63%
FCFM	5.25%

ROA(3y)6.79%

ROA(5y)2.22%

ROE(3y)17.94%

ROE(5y)5.55%

ROIC(3y)9.9%

ROIC(5y)N/A

ROICexc(3y)12.02%

ROICexc(5y)N/A

ROICexgc(3y)13.16%

ROICexgc(5y)N/A

ROCE(3y)12.97%

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y25.96%

GM growth 5Y12.54%

F-Score5

Asset Turnover1.24

Health

		Industry Rank	Sector Rank
Debt/Equity	0.96
Debt/FCF	5.19
Debt/EBITDA	2.74
Cap/Depr	45.51%
Cap/Sales	0.9%
Interest Coverage	5.26
Cash Conversion	65.65%
Profit Quality	110.63%
Current Ratio	2.2
Quick Ratio	1.59
Altman-Z	3.13

F-Score5

WACC8.18%

ROIC/WACC1.2

Cap/Depr(3y)110.02%

Cap/Depr(5y)97.64%

Cap/Sales(3y)1.65%

Cap/Sales(5y)1.54%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-39.71%

EPS 3Y-27.83%

EPS 5Y-18.78%

EPS Q2Q%25.81%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)18.02%

Revenue growth 3Y4.46%

Revenue growth 5Y5.68%

Sales Q2Q%36.07%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-2.87%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-16.94%

FCF growth 3YN/A

FCF growth 5Y49.49%

OCF growth 1Y-24.44%

OCF growth 3YN/A

OCF growth 5Y28.86%

KEWAUNEE SCIENTIFIC CP (KEQU) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens